NCT06862869 2026-03-06Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant TherapyHoffmann-La RocheRecruiting800 enrolled
NCT06532149 2024-08-09EROSFondazione Policlinico Universitario Agostino Gemelli IRCCSRecruiting80 enrolled